Ultrastructure alterations in adriamycin-resistant and cisplatin-resistant human ovarian cancer cell lines exposed to nonlethal ultrasound

International Journal of Gynecological Cancer

Volumn 15, Issue 3, 2005, Pages 462-467

  Yu, Tinghe ^a   Huang, X ^a   Jiang, S ^b   Hu, K ^a   Kong, B ^b   Wang, Z ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Chemoresistance; Cytochrome C; Ovarian cancer; Ultrasonic therapy; Ultrastructure

Indexed keywords

CISPLATIN; CYTOCHROME C; DOXORUBICIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL ULTRASTRUCTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRION; OVARY CANCER; PRIORITY JOURNAL; ULTRASOUND;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; CYTOCHROMES C; CYTOSOL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MITOCHONDRIA; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; ULTRASONIC THERAPY; ULTRASONICS;

EID: 18944387321     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15309.x     Document Type: Article

References (37)

1. Coleman AJ, Saunders JE. A review of the physical properties and biological effects of the high amplitude acoustic fields used in extracorporeal lithotripsy. Ultrasonics 1993;31:75-89.
2. Sur P, Ghosh P, Bag SP, Sur B, Chatterjee SN. On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumor. Chemotherapy 1999;45:360-9.
3. Tachibana K, Tachibana S. Application of ultrasound energy as a new drug delivery system. Jpn J Appl Phys 1999;38:3014-9.
4. ter Haar G. Acoustic surgery. Phys Today 2001;54:29-34.
5. Saito K, Miyake K, McNeil PL, Kato K, Yago K, Sugai N. Plasma membrane disruption underlines injury of the corneal endothelium by ultrasound. Exp Eye Res 1999;68:431-7.
6. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999;353:1409.
7. Yu T, Wang G, Cai H, Wang Z. Effects of ultrasound of nonlethal dosage on ultrastrucrure of human ovarian carcinoma cell line 3AO in vitro. Chin J Ultrasound Med 1999;15:647-8.
8. Ogawa K, Tachibana K, Uchida T et al. High-resolution scanning electron microscopic evaluation of cell-membrane porosity by ultrasound. Med Electron Microsc 2001;34:249-53.
9. Coukos G, Rubin SC. Chemotherapy resistance in ovarian cancer: new molecular perspectives Obstet Gynecol 1998;91:783-92.
10. Arts HJG, Van Der Zee AGJ, De Jong S, De Vries, EGE. Options for modulation of drug resistance in ovarian cancer. Int J Gynecol Cancer 2000;10(Suppl. 1):47-52.
11. Yu T, Hu K, Bai J, Wang Z. Reversal of adriamycin resistance in ovarian carcinoma cell line by combination of verapamil and low-level ultrasound. Ultrason Sonochem 2003;10:37-40.
12. Yu T, Huang X, Hu K, Bai J, Wang Z. Mechanisms of reversal of adriamycin resistance in human ovarian carcinoma cell line by ultrasound. Int J Gynecol Cancer 2004;14:76-81.
13. Zhou YZ, Chen HZ, Yang QY, Liu SQ, Hou HY. Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance. Natl Med J China 1996;76:680-3.
14. Caliaro MJ, Vitaux P, Lafon C et al. Multifactorial mechanism for potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines. Br J Cancer 1997;75:333-40.
15. Johannes EJ, Kaulesar DMKS, Bijma AM, Mulder PGH. Effects of high-energy shockwaves in normal human fibroblast in suspension. J Surg Res 1994;57:677-81.
16. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
17. Miller MW, Miller DL, Brayman AA. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 1996;22:1131-54.
18. Agarwal R, Kaye SB. Ovarian cancers: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 2003;3:502-16.
19. Sood AK, Buller RE. Drug resistance in ovarian cancer: from the laboratory to the clinic. Obstet Gynecol 1998;92:312-9.
20. Fruehauf JP. In vitro assay-assisted treatment selection for women with breast or ovarian cancer. Endocr Relat Cancer 2002;9:171-82.
21. Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA. cis-Diamminedichloroplatinum (II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123) 2: evidence for mitochondrial involvement. Cancer Res 1994;54:1497-502.
22. Dong Y, Berners-Price SJ, Thorburn DR et al. Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy. Biochem Pharmacol 1997;53:1673-82.
23. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
24. Seller WR, Fisher DE. Apoptosis and cancer drug targeting. J Clin Invest 1999;104:1655-61.
25. Zhivotovsky B, Joseph B, Orrenius S. Tumor radiosensitivity and apoptosis. Exp Cell Res 1999;248:10-7.
26. Finkel E. Does cancer therapy trigger cell suicide? Science 1999;286:2256-8.
27. Ashush H, Rozenszajn LA, Blass M et al. Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 2000;60:1014-20.
28. Stanton MT, Ettarh R, Arango D, Tonra M, Brennan PC. Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine. Life Sci 2001;68:1471-5.
29. Yu T, Bai J, Hu K, Wang Z. Biological effects of ultrasound exposure on adriamycin-resistant and cisplatin-resistant human ovarian carcinoma cell lines in vitro. Ultrason Sonochem 2004;11:89-94.
30. Shelling AN. Role of p53 in drug resistance in ovarian cancer. Lancet 1997;349:744-5.
31. Henkels KM, Turchi JT. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res 1999;59:3077-83.
32. Bossy-Wetzell E, Newmeyer DD, Green DR. Mitochondrial cytochrome C release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998;17:37-49.
33. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001;98:2603-14.
34. Yang J, Liu X, Bhalla K. et al. Prevention of apoptosis by Bcl-2: release of cytochrome C from mitochondria blocked. Science 1997;275:1129-32.
35. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome C from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
36. Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Marek Los M. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001;98:1542-8.
37. Cardinale A, Lagalla R, Giambanco V, Aragona F. Bioeffects of ultrasound: an experimental study on human embryos. Ultrasonics 1991;29:261-3.